Αποτελέσματα Αναζήτησης
Z79.899 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2025 edition of ICD-10-CM Z79.899 became effective on October 1, 2024. This is the American ICD-10-CM version of Z79.899 - other international versions of ICD-10 Z79.899 may differ.
4 Ιαν 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
16 Οκτ 2020 · ABSTRACT: The available antiretroviral (ARV) drugs for the treatment of HIV have expanded since 2018. Novel types of ARVs with new mechanisms of action have been approved, including ibalizumab-uiyk and fostemsavir.
31 Ιουλ 2024 · The following table lists HIV medicines recommended for the treatment of HIV infection in the United States, based on the U.S. Department of Health and Human Services (HHS) HIV and AIDS medical practice guidelines. All of these drugs are approved by the U.S. Food and Drug Administration (FDA).
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.
3 Ιαν 2023 · Objective Based on a critical evaluation of new data, to provide clinicians with recommendations on use of antiretroviral drugs for the treatment and prevention of HIV, laboratory monitoring, care of people aging with HIV, substance use disorder and HIV, and new challenges in people with HIV, including COVID-19 and monkeypox virus infection.
22 Απρ 2024 · The Centers for Medicare & Medicaid Services (CMS) last year proposed to transition coverage of oral or injectable HIV pre-exposure prophylaxis (PrEP) drugs from Medicare Part D to Part B. PrEP...
